KRAS and combined KRAS/TP53 mutations in locally advanced rectal cancer are independently associated with decreased response to neoadjuvant therapy

BACKGROUND: The response of rectal cancers to neoadjuvant chemoradiation (CRT) is variable, but tools to predict response remain lacking. We evaluated whether KRAS and TP53 mutations are associated with pathologic complete response (pCR) and lymph node metastasis after adjusting for neoadjuvant regi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg Oncol
Main Authors: Chow, Oliver S., Kuk, Deborah, Keskin, Metin, Smith, J. Joshua, Camacho, Niedzica, Pelossof, Raphael, Chen, Chin-Tung, Chen, Zhenbin, Avila, Karin, Weiser, Martin R., Berger, Michael F., Patil, Sujata, Bergsland, Emily, Garcia-Aguilar, Julio
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5047012/
https://ncbi.nlm.nih.gov/pubmed/27020587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-016-5205-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados